Mpm Bioventures 2018, L.p. sold $462k of TRDA
owner at Entrada Therapeutics, Inc.. 62,714 shares at an average of $7.36, traded Aug 24, 2026, filed Aug 26, 2026.
Score components
- +12Role10% owner
- +17Trade size$462k at market
- 0Share of holdings soldSold 1.4% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231919-26-001106, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -21,623 | $7.34 | $159k | 4,359,439 | Aug 26, 2026 |
| Aug 25, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -26,522 | $7.54 | $200k | 4,332,917 | Aug 26, 2026 |
| Aug 26, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -14,569 | $7.06 | $103k | 4,318,348 | Aug 26, 2026 |
Related signals
Other insiders at Entrada Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. owner | $1.9M 259,837 shares | -6% | |
| 45Moderate | Entrada Therapeutics, Inc. | Mpm Bioventures 2018, L.p. owner | $1.9M 259,837 shares | -6% | |
| 40Moderate | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. owner | $617k 86,482 shares | -2% | |
| 40Moderate | Entrada Therapeutics, Inc. | Mpm Bioventures 2018, L.p. owner | $617k 86,482 shares | -2% | |
| 40Moderate | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. owner | $616k 86,914 shares | -2% | |
| 40Moderate | Entrada Therapeutics, Inc. | Mpm Bioventures 2018, L.p. owner | $616k 86,914 shares | -2% | |
| 37Weak | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. owner | $462k 62,714 shares | -1% | |
| 37Weak | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. owner | $432k 62,811 shares | -2% | |
| 48Moderate | Entrada Therapeutics, Inc. | Kush Parmar director | $1.1M 155,255 shares | -5% | |
| 42Moderate | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. owner | $807k 116,474 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.